You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. An innovative in situ cell reprogramming technology for cancer treatment

    SBC: QURGEN, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): We invented an innovative protein induced Pluripotent Stem Cells (piPSCs) technology that generates piPSCs from normal fibroblast and cancer cells within 1-week with 90 4% conversion efficiency. Such high conversion efficiency enables us to pioneer an in situ cell reprogramming technology within the cancers of cancer-bearing animals. Instead of generating iPSCs ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Accurate Prostate Cancer Diagnosis for Active Surveillance Patients Using a Novel

    SBC: ProDevice Medical Supplies and Equipment LLC            Topic: NCI

    Project Abstract Active surveillance (AS) is becoming more accepted as a reasonable treatment option for men with low-risk prostate cancer (i.e. Gleason score 6, clinical stage T2a, PSA lt 10). Many AS protocols at major institutions call for a prostate saturation biopsy after initial diagnosis to confirm that the patient has no areas of higher-risk prostate cancer. For most patients who underwent ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Hepatitis C Virus RNA-Targeted Therapeutics

    SBC: VIOGEN BIOSCIENCES, LLC            Topic: NIAID

    DESCRIPTION (provided by applicant): Hepatitis C virus (HCV) infection is a significant human health issue, accounting for 50% of liver transplants in the US, with approximately 170 million persons infected worldwide. The current standard of care therapy of PEGylated-interferon and ribavirin is effective in only about 50% of patients, with severe side effects and contraindications limiting patient ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Novel scFv-Antibody Fusion siRNA Carrier Protein for Macroglobulinemia Treatment

    SBC: SIRNAX, Inc.            Topic: NCI

    This goal of this project is to develop an innovative process for treating patients with Waldenstr m's macroglobulinemia by suppressing the production of IgM. Waldenstr m's macroglobulinemia is incurable and fatal. The manifestations of this disease that are due to high concentrations of monoclonal IgM are hyperviscosity with headache, fatigue, impaired cognition, confusion, and stroke, ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Development of a Neuroprotective Agent For Cerebral Palsy Prevention

    SBC: Zietchick Research Institute, LLC            Topic: NICHD

    DESCRIPTION (provided by applicant): Cerebral palsy (CP), the most common physical disability in childhood, afflicts more than 800,000 Americans and many more worldwide. In addition to motor difficulties, many children with CP also suffer from intellectualdisability, epilepsy, nutritional problems, and language dysfunction. Furthermore, almost 90% of CP-associated brain injuries occur in utero or ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Selective activation of the vagus nerve as an improved therapy for heart failure

    SBC: BLACKROCK MICROSYSTEMS, INC            Topic: NHLBI

    DESCRIPTION (provided by applicant): The goal of the proposed project is to alleviate the enormous public health burden of heart failure. Heart failure leads to significant morbidity and mortality, affects almost five million Americans, and results in morethan 35 billion dollars in annual healthcare costs. Current pharmacological and surgical treatments are only moderately effective and can have s ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Modeling and Simulation for Design, Development, Testing and Evaluation of Autonomous Multi-Agent Models

    SBC: SOAR TECHNOLOGY INC            Topic: AF15AT14

    ABSTRACT: The rapid continued development of unmanned air systems (UAS) is enabling new mission types, in-creased mission effects, and increased airman safety. However, these advances also present numerous challenges to airman-machine interaction, tactics development, and defense. The rapid development pace has produced a situation where new technologies are outpacing the knowledge of how best to ...

    STTR Phase I 2015 Department of DefenseAir Force
  8. An MPM-based Multiscale Framework for Simulations of Mesoscale Heterogeneous PBXs

    SBC: WASATCH MOLECULAR, INC.            Topic: AF15AT28

    ABSTRACT: We will develop a multiscale molecular dynamics/material point method (MD/MPM) methodology for determining the response of PBXs to a wide range of loading conditions as a function of mesoscale structure with emphasis on accurate representation of interfacial physics. The initial material of choice will be HMX + DOA plasticized HTPB binder. Velocity-dependent grain-grain and viscoelastic ...

    STTR Phase I 2015 Department of DefenseAir Force
  9. Biomimetic Material Solutions for the Stabilization of Labile Reagents

    SBC: Technology Holding, LLC            Topic: AF15AT29

    ABSTRACT: Elimination of the cold chain is of vital importance for the ability to treat injured warfighters in the field and behind enemy lines. The application of an already FDA approved reagent for the stabilization of labile reagents will allow for minimal development time delaying the fielding of a new technology to fill this role. Collagen has been used extensively since the 1980s as an appro ...

    STTR Phase I 2015 Department of DefenseAir Force
  10. Ultra-High-Performance Concrete

    SBC: METNA CO            Topic: AF12BT04

    Ultra-high-performance concrete (UHPC) offers superior properties for structural applications. Existing UHPC design and production methods employ special materials and mixers. This project is developing mix design and fabrication methods for reliable production of UHPC with local materials and facilities. The Phase I project devised material selection criteria, proportioning methods and mixing pro ...

    STTR Phase II 2015 Department of DefenseAir Force
US Flag An Official Website of the United States Government